(Q48343468)

10 February 2018

title

Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder. (English)

1 reference

10 February 2018

main subject

firocoxib

1 reference

transitional cell carcinoma

ChEBI release 2020-05-28

ChEBI ID

76136

1 reference

1 reference

1

D W Knapp

1 reference

10 February 2018

author name string

C J Henry

2

1 reference

10 February 2018

W R Widmer

3

1 reference

10 February 2018

K M Tan

4

1 reference

10 February 2018

G E Moore

5

1 reference

10 February 2018

J A Ramos-Vara

6

1 reference

10 February 2018

M D Lucroy

7

1 reference

10 February 2018

C B Greenberg

8

1 reference

10 February 2018

S N Greene

9

1 reference

10 February 2018

A H Abbo

10

1 reference

10 February 2018

P D Hanson

11

1 reference

10 February 2018

R Alva

12

1 reference

10 February 2018

P L Bonney

13

1 reference

10 February 2018

publication date

3 December 2012

1 reference

10 February 2018

Journal of Veterinary Internal Medicine

published in

1 reference

10 February 2018

volume

27

1 reference

10 February 2018

page(s)

126-133

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Renal adverse effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Amelioration of cisplatin-induced rat renal lesions by a cyclooxygenase (COX)-2 selective inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Biology of Cox-2: an application in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12013

21 January 2018

Identifiers

DOI

10.1111/JVIM.12013

1 reference

10 February 2018

PubMed ID

23205923

1 reference

10 February 2018